News

Novaliq GmbH announced that NovaTears, a novel topical treatment of dry eye disease (DED) and meibomian gland dysfunction (MGD), is now also available in Australia. Dry eye is a…
Read More...

AbbVie and Calibr announced a collaboration to develop T-cell therapies aimed primarily at cancer, including solid tumors. This collaboration broadens AbbVie's oncology research to…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) and granted Priority Review for baloxavir marboxil as a single-dose, oral…
Read More...

Aquinox Pharmaceuticals announced that the Phase 3 LEADERSHIP 301 clinical trial evaluating once-daily, oral rosiptor (AQX-1125) for the treatment of interstitial cystitis/bladder pain…
Read More...

The center will be based around LUMICKS' C-Trap optical tweezers-fluorescence microscope, which for the first time enables real-time observation and probing of biomolecular…
Read More...

In the quest to develop a drug to effectively treat aggressive prostate cancer, NucleoBio Inc. has demonstrated efficacy for its newest product, Prostreat. Prostreat outperforms…
Read More...

Starpharma and Mundipharma today announced they have signed a licence agreement for the sales and marketing rights to VivaGel BV for 43 countries in Europe, Russia, the Commonwealth of…
Read More...

AbbVie and Calico announced an extension of their collaboration to discover, develop and bring to market new therapies for patients with age-related diseases, including…
Read More...

IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics technology, announced its collaboration with Nektar Therapeutics. The…
Read More...

Erimos Pharmaceuticals announced in collaboration with Adult Brain Tumor Consortium (ABTC) and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, initiation of a multi-center…
Read More...

The U.S. Food and Drug Administration approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut…
Read More...

Shire plc announced that the United States Food and Drug Administration (FDA) has approved the company's first submission for its new plasma manufacturing facility near Covington,…
Read More...

Evotec AG announced that its strategic alliance (TargetBCD) with Sanofi in the field of diabetes has reached its second beta cell therapy milestone, resulting in a payment of € 3…
Read More...

Roche announced that it has signed a collaboration agreement and investment in Care Innovations, a leader in telehealth solutions that remotely connects people living with chronic…
Read More...

Mustang Bio announced that it has opened a CAR T cell therapy manufacturing facility at UMass Medicine Science Park in Worcester, Mass. The 27,000 sq. ft. facility will support the…
Read More...

WuXi Biologics and Harbour BioMed announced an initial strategic collaboration for the development and manufacturing of Harbour's leading HCAb antibody. The collaboration with WuXi…
Read More...

Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during…
Read More...

Samsung BioLogics announced that it has licensed by the Health Canada for manufacturing a monoclonal antibody Drug Substance at its first plant. This is a great milestone for…
Read More...

Syneos Health, the only fully integrated biopharmaceutical solutions organization, and Elligo Health Research, the only platform that brings clinical research direct to clinical health…
Read More...

Comprehend Systems announced it is joining the Veeva Partner Program. As a Veeva partner, Comprehend will integrate solutions with Veeva Vault EDC and Veeva Vault CTMS to provide…
Read More...